1-11 of 11
Bhupinder Sharma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Transplantation in First Remission in the Rituximab Era in Patients with Mantle Cell Lymphoma: Experience from the Royal Marsden Hospital

Farheen Mir, Anna Robinson, Mark Edward Ethell, Michael Potter, Emma Nicholson, Chloe Anthias, Sandra Easdale, Carlos Gonzalez-Arias, Amit Sud, Claire E. Dearden, Ian Chau, David Cunningham, Dima El-Sharkawi, Bhupinder Sharma, Sunil Iyengar
Journal: Blood
Blood (2022) 140 (Supplement 1): 9366–9367.
https://doi.org/10.1182/blood-2022-166198
Published: 2022
Journal Articles

Does R-IPI Remain Predictive of Relapse Risk for Patients with DLBCL Achieving a Complete Remission with Frontline Therapy: Landmark Analysis of Two Large Prospective Clinical Trials

Dima El-Sharkawi, Tasneem Elnafie, Sarah Thompson, Louise Stanton, Nicholas Counsell, Amit Sud, Ian Chau, Bhupinder Sharma, Peter Johnson, David C. Linch, Sunil Iyengar, Andrew Davies, David Cunningham
Journal: Blood
Blood (2022) 140 (Supplement 1): 7908–7909.
https://doi.org/10.1182/blood-2022-167852
Published: 2022
Journal Articles

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cost Evaluation Study of Management and Surveillance, and Review of the Recent USA and UK Guidelines

Aia S Mehdi, Rachel O'Connell, Michael Potter, Chris Marshall, Liza Van Kerckhoven, Sunil Iyengar, Emma Nicholson, Dima El-Sharkawi, Marios Tasoulis, David Cunningham, Bhupinder Sharma
Journal: Blood
Blood (2021) 138 (Supplement 1): 4014.
https://doi.org/10.1182/blood-2021-153675
Published: 2021
Journal Articles

The Value of Follow-up Following Complete Remission with Frontline Chemotherapy for DLBCL

Sarah Thompson, Tasneem Elnafie, Tatiana Elwes, Wilam Alfred, Alinane Munyenyembe, Kabir Mohammed, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR, Ian Chau, MD, David Cunningham, MD FRCP, FMedSci, Sunil Iyengar, MD FRCPath, PhD, Dima El-Sharkawi
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-141982
Published: 2020
Journal Articles

Implementing a Specialist Integrated Haematological Malignancy Imaging Reporting Paradigm to Lymphoma Radiology Assessment Can Significantly Improve the Quality of Data for Patient Management and Clinical Research

Preethika Mahalingam, MBBS, BSc, Sunil Iyengar, MBBS, FRCPath, PhD, Dima El-Sharkawi, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR
Journal: Blood
Blood (2019) 134 (Supplement_1): 5835.
https://doi.org/10.1182/blood-2019-126155
Published: 2019
Journal Articles

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Vasiliki Michalarea, MD, Dima El-Sharkawi, MBBS BSc FRCPath MD, Siraj Yusuf, Mary Gleeson, Laura Hickmott, Andrew Wotherspoon, Ayoma Attygalle, Simon O'Connor, Bhupinder Sharma, Yong Du, Imene Zerizer, Alan Horwich, Gillian Ross, Andrea Kuhnl, Sunil Iyengar, Ian Chau, MD, David Cunningham
Journal: Blood
Blood (2018) 132 (Supplement 1): 4240.
https://doi.org/10.1182/blood-2018-99-119560
Published: 2018
Journal Articles

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Charlotte Wilding, BSc, MBChB, Farheen Mir, MBBS, Indu Mitra, Bhupinder Sharma, Larissa Sena, Andrew Wotherspoon, David Cunningham, MD FRCP, Ian Chau, MD, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Sunil Iyengar
Journal: Blood
Blood (2017) 130 (Supplement 1): 2786.
https://doi.org/10.1182/blood.V130.Suppl_1.2786.2786
Published: 2017
Journal Articles

WB-DWI MRI Scanning Outperforms FDG PET-CT for the Assessment of Myeloma Disease Burden

Charlotte Pawlyn, MB BChir, Martin F Kaiser, MD, Lucy Fowkes, MD, John R Jones, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD, David Collins, BA, MInstP, Bhupinder Sharma, MD, Angela Riddell, MD, Christina Messiou, MD
Journal: Blood
Blood (2015) 126 (23): 1758.
https://doi.org/10.1182/blood.V126.23.1758.1758
Published: 2015
Journal Articles

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Mary Gleeson, FRCPath, Eliza A Hawkes, MD, Clare Peckitt, MSc, Andrew Wotherspoon, FRCPath, Ayoma Attygalle, PhD, Bhupinder Sharma, MD, Yong Du, MD, Mark Ethell, MD, Michael Potter, PhD, Claire Dearden, MD, Alan Horwich, MD, Ian Chau, MD, David Cunningham, FMedSci
Journal: Blood
Blood (2014) 124 (21): 1719.
https://doi.org/10.1182/blood.V124.21.1719.1719
Published: 2014
Journal Articles

Successful Long-Term Outcomes in Patients with Lymphoma Achieving Only Partial Response on [ 18 f]FDG-PET Prior to Allogeneic Transplant

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD
Journal: Blood
Blood (2014) 124 (21): 1249.
https://doi.org/10.1182/blood.V124.21.1249.1249
Published: 2014
Journal Articles

Residual Disease on FDG-PET and Multiple Lines of Prior Therapy Predict Poorer Outcomes Following Autologous Hematopoietic Stem Cell Transplantation for Lymphoma

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD
Journal: Blood
Blood (2014) 124 (21): 3971.
https://doi.org/10.1182/blood.V124.21.3971.3971
Published: 2014